Cargando…

Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants

Heparan sulfate (HS) acts as a co-receptor of angiotensin-converting enzyme 2 (ACE2) by interacting with severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein (SGP) facilitating host cell entry of SARS-CoV-2 virus. Heparin, a highly sulfated version of heparan sulfa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gelbach, Adrianne L., Zhang, Fuming, Kwon, Seok-Joon, Bates, John T., Farmer, Andrew P., Dordick, Jonathan S., Wang, Chunyu, Linhardt, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420978/ https://www.ncbi.nlm.nih.gov/pubmed/36046608 http://dx.doi.org/10.3389/fmolb.2022.912887

Ejemplares similares

Interactions of heparin with key glycoproteins of human respiratory syncytial virus
por: Shi, Deling, et al.
Publicado: (2023)

Structural Characteristics of Heparin Binding to SARS-CoV-2 Spike Protein RBD of Omicron Sub-Lineages BA.2.12.1, BA.4 and BA.5
por: Shi, Deling, et al.
Publicado: (2022)

Structural Features of Heparin and Its Interactions With Cellular Prion Protein Measured by Surface Plasmon Resonance
por: Kim, So Young, et al.
Publicado: (2020)

Molecular determinants of the interaction between HSV-1 glycoprotein D and heparan sulfate
por: Gandy, Lauren A., et al.
Publicado: (2022)

The Sulfation Code of Tauopathies: Heparan Sulfate Proteoglycans in the Prion Like Spread of Tau Pathology
por: Mah, Dylan, et al.
Publicado: (2021)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
por: Hoter, Abdullah, et al.
Publicado: (2022)

Small-molecule compound from AlphaScreen disrupts tau-glycan interface
por: Faris, Shannon, et al.
Publicado: (2022)

Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer
por: Yue, Jingwen, et al.
Publicado: (2021)

An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome–Coronavirus
por: Kathiravan, Muthu Kumaradoss, et al.
Publicado: (2021)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021)

Interactions of marine sulfated glycans with antithrombin and platelet factor 4
por: Zhang, Wenjing, et al.
Publicado: (2022)

Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions
por: Kim, So Young, et al.
Publicado: (2020)

Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021)

Synthesis and Cytotoxic Activity of Novel Indole Derivatives and Their in silico Screening on Spike Glycoprotein of SARS-CoV-2
por: Gobinath, Perumal, et al.
Publicado: (2021)

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
por: Datta, Payel, et al.
Publicado: (2021)

Corrigendum: Synthesis and Cytotoxic Activity of Novel Indole Derivatives and Their in silico Screening on Spike Glycoprotein of SARS-CoV-2
por: Gobinath, Perumal, et al.
Publicado: (2021)

Computational Saturation Mutagenesis of SARS-CoV-1 Spike Glycoprotein: Stability, Binding Affinity, and Comparison With SARS-CoV-2
por: Sobitan, Adebiyi, et al.
Publicado: (2021)

Evaluating the immunogenicity of heparin and heparin derivatives by measuring their binding to platelet factor 4 using biolayer interferometry
por: Chen, Qingqing, et al.
Publicado: (2022)

In silico design of refined ferritin-SARS-CoV-2 glyco-RBD nanoparticle vaccine
por: Masoomi Nomandan, Seyedeh Zeinab, et al.
Publicado: (2022)

Characterizing Heparin Tetrasaccharides Binding to Amyloid-Beta Peptide
por: Zhou, Xiang, et al.
Publicado: (2022)

Antigen–Antibody Complex-Guided Exploration of the Hotspots Conferring the Immune-Escaping Ability of the SARS-CoV-2 RBD
por: Fung, Kit-Man, et al.
Publicado: (2022)

Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4
por: Sin, Yun Jin Ashley, et al.
Publicado: (2022)

Deep Mutational Scanning of Viral Glycoproteins and Their Host Receptors
por: Narayanan, Krishna K., et al.
Publicado: (2021)

Lipid environment determines the drug-stimulated ATPase activity of P-glycoprotein
por: Tran, Nghi N. B., et al.
Publicado: (2023)

Editorial: Interactions Between Proteins and Biomacromolecules: Tools and Applications
por: Zhang, Qunye, et al.
Publicado: (2021)

Editorial: Interactions between proteins and biomacromolecules: Tools and applications (volume II)
por: Zhang, Fuming, et al.
Publicado: (2022)

Structural Requirements and Plasticity of Receptor-Binding Domain in Human Coronavirus Spike
por: Li, Yajuan, et al.
Publicado: (2022)

Glycosylation-on-a-Chip: A Flow-Based Microfluidic System for Cell-Free Glycoprotein Biosynthesis
por: Aquino, Alicia K., et al.
Publicado: (2021)

SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development
por: Malik, Yashpal S., et al.
Publicado: (2021)

Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production
por: Zhao, Xiaohui, et al.
Publicado: (2021)

In-silico investigation of systematic missense mutations of middle east respiratory coronavirus spike protein
por: Rhoades, Raina, et al.
Publicado: (2022)

Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins—An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic
por: Yu, Mingjia, et al.
Publicado: (2021)

Engineered heparins as new anticoagulant drugs
por: Vaidyanathan, Deepika, et al.
Publicado: (2016)

Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses
por: Vangelista, Luca, et al.
Publicado: (2020)

DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2
por: Cleri, Fabrizio, et al.
Publicado: (2021)

The Molecular Basis of the Effect of Temperature on the Structure and Function of SARS-CoV-2 Spike Protein
por: Khan, Faez Iqbal, et al.
Publicado: (2022)

Spike S1 domain interactome in non-pulmonary systems: A role beyond the receptor recognition
por: Iacobucci, Ilaria, et al.
Publicado: (2022)

Cytoplasmic tail determines the membrane trafficking and localization of SARS-CoV-2 spike protein
por: Li, Qinlin, et al.
Publicado: (2022)

Crystal polymorphism in fragment-based lead discovery of ligands of the catalytic domain of UGGT, the glycoprotein folding quality control checkpoint
por: Caputo, Alessandro T., et al.
Publicado: (2022)

Suramin binds and inhibits infection of SARS-CoV-2 through both spike protein-heparan sulfate and ACE2 receptor interactions
por: Kwon, Paul S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kjqvdaqi9km910mtd1hn9m74cc